- B2B
- Scale StageRapidly increasing operations
Evisort Funding
$0
55 rounds
Harvard Innovation Labs
Evisort is active in the following markets / industries: SaaS, enterprise software, analytics, artificial intelligence, software, legal, text analytics, document management and Legal Tech. The company has secured funding across 5 rounds and is valued at $0. Their most recent funding was raised on May 11, 2022.
Funding Rounds
B
$35000000A
$15000000S
$4500000U
$1100000Investors of Evisort
Early Stage & Growth Investor
General Partner at Vertex Ventures. Founded 2 companies (Kiva Software, Loudcloud/Opsware). 20 years of Entrepreneur/Advisor/Board/Investor experience.
Co-Founder & Managing Partner @Biospring Partners
Biospring invests in businesses that serve the world's largest pharmaceutical companies to accelerate and improve drug development.
Early Stage Technology Investor
Early Stage Technology Investor
Bob Allard
CEO/Managing Partner at consultancy ExtensionEngine (clients include Harvard BSchool, Fidelity, Zmags, PHT). Investor in i-Nalysis, iSpecimen, momedx.
Amity Ventures
We support founders building category-defining businesses
Believer in Mentor Backed Entrepreneurship. Wrote software used by 3.5 million people. Love Living!
Serial entrepreneur, angel and advisor to startups. Founded Prospectiv and Global Marketing. Knack for customer acquisition and marketing.